From trash to leucocytes: what are we filtering and why?
作者信息
Mitchell Simon J
机构信息
Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand.
出版信息
J Extra Corpor Technol. 2006 Mar;38(1):58-63.
Abstract
摘要
相似文献
1
From trash to leucocytes: what are we filtering and why?
J Extra Corpor Technol. 2006 Mar;38(1):58-63.
2
Pericardial suction blood--what are we doing about it?
J Extra Corpor Technol. 2006 Mar;38(1):76.
3
Ultrafiltration techniques and CPB: what we know and what we think we know.
J Extra Corpor Technol. 2006 Mar;38(1):64-5.
4
Comparing oxygen transfer performance between three membrane oxygenators: effect of temperature changes during cardiopulmonary bypass.
Artif Organs. 2007 Apr;31(4):290-300. doi: 10.1111/j.1525-1594.2007.00379.x.
5
Gaseous microemboli: do we finally start to comprehend how to remove them?
J Extra Corpor Technol. 2014 Mar;46(1):67-8.
6
Association of IL6 and IL10 with renal dysfunction and the use of haemofiltration during cardiopulmonary bypass.
Eur J Cardiothorac Surg. 2009 Mar;35(3):511-4. doi: 10.1016/j.ejcts.2008.10.010. Epub 2008 Dec 11.
7
Our experience with using the Pall LG6 leukocyte depleting filter during cardiopulmonary bypass.
Ann Thorac Surg. 1993 Nov;56(5):1216-7. doi: 10.1016/0003-4975(95)90061-6.
8
Haemofiltration during cardiopulmonary bypass.
Perfusion. 1990;5(Suppl):39-51. doi: 10.1177/0267659190005001s07.
9
[Comparison between membrane and bubble oxygenators in cardiopulmonary bypass without donor blood combined with ultrafiltration].
Kyobu Geka. 1987 Feb;40(2):103-7.
10
Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
Artif Organs. 2000 Jan;24(1):43-8. doi: 10.1046/j.1525-1594.2000.06351.x.
本文引用的文献
1
Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit?
Ann Thorac Surg. 2005 Jul;80(1):238-43. doi: 10.1016/j.athoracsur.2005.02.032.
2
Influence of pericardial suction blood retransfusion on memory function and release of protein S100B.
Perfusion. 2004 Nov;19(6):337-43. doi: 10.1191/0267659104pf768oa.
3
Induction and detection of disturbed homeostasis in cardiopulmonary bypass.
Perfusion. 2004;19(5):267-76. doi: 10.1191/0267659104pf757oa.
4
Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction?
Br J Anaesth. 2004 Dec;93(6):789-92. doi: 10.1093/bja/aeh267. Epub 2004 Oct 1.
5
Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease.
Ann Thorac Surg. 2004 Oct;78(4):1339-44. doi: 10.1016/j.athoracsur.2004.04.040.
6
The effects of leukocyte reduction on matrix metalloproteinase release in cardiopulmonary bypass.
J Extra Corpor Technol. 2004 Jun;36(2):185-90.
7
Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass.
Ann Thorac Surg. 2004 Aug;78(2):634-42; discussion 642-3. doi: 10.1016/j.athoracsur.2004.02.091.
8
The inflammatory response to cardiopulmonary bypass: a therapeutic overview.
Perfusion. 2004;19 Suppl 1:S5-12. doi: 10.1191/0267659104pf717oa.
9
Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production?
Perfusion. 2004 Jan;19(1):7-10. doi: 10.1191/0267659104pf703oa.
10
Neutrophil depletion reduces myocardial reperfusion morbidity.
Ann Thorac Surg. 2004 Mar;77(3):956-61. doi: 10.1016/j.athoracsur.2003.10.004.
Zotero 插件